Zimmer Biomet raised its FY 2026 financial guidance after reporting broad-based Q3 sales growth, driven by Hips, S.E.T., and ...

A new host-response blood test from Beckman Coulter and MeMed delivers bacterial-vs-viral results in 15 minutes, aiding ...

The characterization of digital health technologies in vision care has transitioned from a theoretical taxonomy to a highly ...

FDA flagged safety alerts for Teleflex guidewires/catheters over coating particles and Intersurgical breathing tubes over ...

J&J's venture arm JJDC leads financing for Francis Medical's Vanquish prostate ablation system, supporting FDA PMA path for ...

FDA is seeking feedback on a discussion paper weighing the benefits and risks of autonomous and remote-controlled robotic ...

Hyperfine's Q3 revenue topped cash burn for the first time, marking a major step toward capital efficiency and profitability.

AAHKS warns Medicare's 2027 cuts to hip and knee replacement payments threaten procedure volumes, tech adoption, and medtech ...

Divyesh Sharma is a Senior Healthcare Writer at Ailoitte & writes about medical software regulatory pathways and the influence on engineering.

Forget Congress — the real medtech question for 2027 is whether hospital customers can still afford capital equipment ...

Edwards Lifesciences raised its 2026 guidance for the third time this year, citing strong TAVR growth, new clinical data, and ...

Boston Scientific's SIMPLAAFY data show aspirin alone or reduced-dose anticoagulation matches DAPT after Watchman Flx Pro ...